Login with your work email address to view charts. No credit card required.
| Art Unit: | 1614 — Drug, bio-affecting and body treating compositions |
|---|---|
| Group: | 1610 — Pharmaceutical and Agricultural Compositions; Plant Growth Regulating Compositions: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs; In vivo Diagnostic Agents |
| Classes: |
424 — Drug, bio-affecting and body treating compositions 514 — Drug, bio-affecting and body treating compositions 600 — Surgery 623 — Prosthesis (i.e., artificial body members), parts thereof, or aids and accessories therefor 604 — Surgery 504 — Plant protecting and regulating compositions 435 — Chemistry: molecular biology and microbiology 128 — Surgery 606 — Surgery 506 — Combinatorial chemistry technology: method, library, apparatus |
| Phone: | (571) 270-3769 |
| Email: | robert.cabral@uspto.gov |
| Location: | VA 22314 |
| Title: | Pat Examnr Gen Chem |
| Service: | 15 years |
| Grade: | GS-14 |
| 3-Year Grant rate: | 65% over 398 cases |
|---|---|
| Difficulty: | Harder |
| Difficulty Percentile: | 67th
|
With Examiner Cabral, you have a 65% chance of getting an issued patent by 3 years after the first office action. Examiner Cabral is a harder examiner and in the 67th percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Cabral, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Cabral's grant rate is higher than that of Art Unit 1614 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Cabral | 2.1 |
| Art Unit 1614 | 2.1 |
Examiner Cabral has granted 210 of 321 cases without any applicant-requested interviews for a grant rate of 65%.
Examiner Cabral has granted 49 of 77 cases with at least one applicant-requested interview for a grant rate of 64%.
With Examiner Cabral, conducting an interview decreases your chance of getting a patent granted by 2%.
| Number | Title | OA Rejections | Status | IFW |
|---|---|---|---|---|
| 17638512 | Novel Theranostic Agents For Psma Positive Cancers | Rejection information available with a Premium Stats subscription. See our pricing. | Patented | View |
| 17768321 | Sealing Material For A Medical Implant | Patented | View | |
| 18004827 | Contrast Agents For Detection Of Enzyme Activities Based On Melanin Synthesis | Patented | View | |
| 17661305 | Fluorescent Contrast Agent With Targeting Function, And Preparation Method And Use Thereof | Patented | View | |
| 17917377 | B7h3 Antibodies With Chelators | Abandoned | View | |
| 17422414 | Drug Delivery System And Method | Abandoned | View | |
| 19220988 | Dispenser And Method Of Use Thereof | Patented | View | |
| 17975454 | Compositions And Methods For Treating Biofilms Without Inducing Antimicrobial Resistance | Patented | View | |
| 17566335 | Combination Cancer Immunotherapy With Pentaaza Macrocyclic Ring Complex | Patented | View | |
| 16958647 | Drug Delivery Systems For Treatment Of Infections | Patented | View | |
| 17617462 | Surface Enhanced Raman Scattering Nanoparticles And Their Use In Detecting And Imaging Oxidative Stress | Patented | View | |
| 17598509 | Ph-Dependent Composition Matters Useful For Study And Diagnosis Of Alzheimer's Disease | Patented | View | |
| 17943311 | Radiotherapy Gel And Method Of Preparing The Same | Patented | View | |
| 17759754 | Methods Of Treating Psma-Positive Cancer Using Radionuclide Therapy | Abandoned | View | |
| 17759912 | Compounds And Compositions For Retinal Injury Detection And Methods Of Using Same | Abandoned | View | |
| 17296379 | Nanocarrier Systems For Imaging And Delivery Of Active Agents | Patented | View | |
| 19204235 | Radiopharmaceutical Compositions For Low Toxicity Actinium In Targeted Radionuclide Therapy | Patented | View | |
| 17425401 | High Density Lipoprotein Mimetic Nanoparticles Using Lipid Conjugated Core Scaffolds | Patented | View | |
| 17633536 | Targeted Nanoparticles Of Well-Defined And Reproducible Sizes | Abandoned | View | |
| 16552576 | Noninvasive Deep Brain Stimulation (Dbs) Using X-Ray-Excited Optical Luminescent (Xeol) Nanomaterials (Nanoscintillators) | Abandoned | View | |
| 18010853 | Anti-Cd38 Antibody And Use Thereof | Patented | View | |
| 18286675 | Radiopharmaceuticals At Different Activity Reference Times | Patented | View | |
| 17740549 | Radioactive Yttrium Phosphate Suspension And Method Of Preparing The Same | Patented | View | |
| 18405670 | Eye Drop Composition | Patented | View | |
| 17738647 | M13 Phage Based Gene Therapy Platform | Patented | View | |
| 18211938 | Nanoparticle Probes And Methods Of Making And Use Thereof | Patented | View | |
| 18543199 | Solid Substrates For Promoting Cell And Tissue Growth | Patented | View | |
| 17609536 | Therapeutic Peptides | Patented | View | |
| 16071290 | Vesicle-Encapsulated Socs | Abandoned | View | |
| 17620312 | Biothiol-Activatable Probe And Method Of Use | Patented | View | |
| 17027286 | Fluorophores For Super-Resolution Imaging | Patented | View | |
| 19002866 | Therapeutics And Method For Treating Osteoarthritis | Patented | View | |
| 17446386 | Apparatus And Methods For Sealing A Vascular Puncture | Patented | View | |
| 16760215 | Liposomal Formulation Of Bacterial Lipopolysaccharide Combined With A Cytotoxic Agent, And Use Thereof In Anti-Tumour Therapy | Patented | View | |
| 18130336 | Nanoparticle Pharmaceutical Delivery System | Patented | View | |
| 17842100 | Acetic Acid And Hypochlorous Acid Compositions For Treatment Of Skin Trauma | Patented | View | |
| 16960393 | Compositions And Methods Relating To Macrophages And/or Monocytes With Adhered Particles | Patented | View | |
| 17047299 | Nanomolecules For The Treatment Of Inflammatory Bowel Diseases | Patented | View | |
| 18516052 | Solid Drug Tablets For Implantable Drug Delivery Devices | Patented | View | |
| 17258846 | Methods And Compositions For Delivery Of Agents Across The Blood-Brain Barrier | Patented | View | |
| 18403636 | Treatment Of A Disease Of The Gastrointestinal Tract With An Immune Modulatory Agent Released Using An Ingestible Device | Abandoned | View | |
| 17456818 | Polymeric Nanoparticles | Abandoned | View | |
| 18121527 | Targeting The Innate Immune System To Induce Long-Term Tolerance And To Resolve Macrophage Accumulation In Atherosclerosis | Patented | View | |
| 17982116 | Compositions Of Hypochlorous Acid And Methods Of Manufacture Thereof | Patented | View | |
| 18355360 | Conformal Coating Of Biological Surfaces | Patented | View | |
| 18341337 | Microbiota Sequence Variants Of Tumor-Related Antigenic Epitopes | Patented | View | |
| 18134247 | Methods And Compositions For Sustained Release Microparticles For Ocular Drug Delivery | Patented | View | |
| 17066418 | Magnetic Microwires For Energy-Transporting Biomedical Applications | Patented | View | |
| 16761114 | Compositions And Methods For Cancer Treatment | Patented | View | |
| 17322577 | Medical Imaging Technique Using X-Ray To Near-Infrared Downconverting Nanopowder | Patented | View |
Subscribe to Premium Examiner Statistics for unlimited access for your law firm.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.